Essais liés3clinical trials
VilleChattanoogalocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Import ClinicalTrials.gov

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
Rimegepant Migraine Phase 4 NCT05207865 Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention COMPLETED
Elismetrep Migraine Phase 3 NCT07645924 A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine RECRUITING
Elismetrep Migraine Phase 3 NCT07674654 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine RECRUITING